Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
September 05 2018 - 8:00AM
Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty
pharmaceutical company committed to advancing patient care, today
announced that members of senior management will participate at the
16th Annual Morgan Stanley Global Healthcare Conference in a
session scheduled for 12:55 p.m. ET, Thursday, September 13, 2018
in New York, NY.
This presentation will be webcast and can be accessed via the
Investor Relations page of the Assertio website at
www.assertiotx.com. A recording of the webcast will be
archived.
About Assertio Therapeutics, Inc.Assertio
Therapeutics is committed to providing responsible solutions to
advance patient care in the Company’s core areas of neurology,
orphan and specialty medicines. Assertio currently markets three
FDA-approved products and continues to identify, license and
develop new products that offer enhanced options for patients that
may be underserved by existing therapies. To learn more about
Assertio, visit www.assertiotx.com.
INVESTOR AND MEDIA CONTACT:John B. Thomas SVP,
Investor Relations and Corporate Communications
jthomas@assertiotx.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Apr 2023 to Apr 2024